Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

ABCB1 C3435T polymorphism is associated with susceptibility to major depression, but not with a clinical response to citalopram in a Turkish population.

Ozbey G, Yucel B, Taycan SE, Kan D, Bodur NE, Arslan T, Percin F, Yuksel N, Guzey C, Uluoglu C.

Pharmacol Rep. 2014 Apr;66(2):235-8. doi: 10.1016/j.pharep.2013.09.004. Epub 2014 Mar 2.

PMID:
24911075
2.

ABCB1 gene polymorphisms are associated with the severity of major depressive disorder and its response to escitalopram treatment.

Lin KM, Chiu YF, Tsai IJ, Chen CH, Shen WW, Liu SC, Lu SC, Liu CY, Hsiao MC, Tang HS, Liu SI, Chang LH, Wu CS, Tsou HH, Tsai MH, Chen CY, Wang SM, Kuo HW, Hsu YT, Liu YL.

Pharmacogenet Genomics. 2011 Apr;21(4):163-70. doi: 10.1097/FPC.0b013e32833db216.

PMID:
20859246
3.

Citalopram enantiomers in plasma and cerebrospinal fluid of ABCB1 genotyped depressive patients and clinical response: a pilot study.

Nikisch G, Eap CB, Baumann P.

Pharmacol Res. 2008 Nov-Dec;58(5-6):344-7. doi: 10.1016/j.phrs.2008.09.010. Epub 2008 Sep 30.

PMID:
18940259
4.

ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression.

Singh AB, Bousman CA, Ng CH, Byron K, Berk M.

Transl Psychiatry. 2012 Nov 27;2:e198. doi: 10.1038/tp.2012.115.

5.

Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder.

Choi MJ, Kang RH, Lim SW, Oh KS, Lee MS.

Brain Res. 2006 Nov 6;1118(1):176-82. Epub 2006 Sep 18.

PMID:
16979146
6.

Association between the functional polymorphism (C3435T) of the gene encoding P-glycoprotein (ABCB1) and major depressive disorder in the Japanese population.

Fujii T, Ota M, Hori H, Sasayama D, Hattori K, Teraishi T, Yamamoto N, Hashikura M, Tatsumi M, Higuchi T, Kunugi H.

J Psychiatr Res. 2012 Apr;46(4):555-9. doi: 10.1016/j.jpsychires.2012.01.012. Epub 2012 Feb 4.

PMID:
22306099
7.

MDR1 gene polymorphism: therapeutic response to paroxetine among patients with major depression.

Mihaljevic Peles A, Bozina N, Sagud M, Rojnic Kuzman M, Lovric M.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Aug 1;32(6):1439-44. doi: 10.1016/j.pnpbp.2008.03.018. Epub 2008 Apr 3.

PMID:
18550244
8.

Serotonin receptor 2A gene polymorphism (-1438A/G) and short-term treatment response to citalopram.

Choi MJ, Kang RH, Ham BJ, Jeong HY, Lee MS.

Neuropsychobiology. 2005;52(3):155-62. Epub 2005 Aug 25.

PMID:
16127283
9.

ABCB1 Genetic Effects on Antidepressant Outcomes: A Report From the iSPOT-D Trial.

Schatzberg AF, DeBattista C, Lazzeroni LC, Etkin A, Murphy GM Jr, Williams LM.

Am J Psychiatry. 2015 Aug 1;172(8):751-9. doi: 10.1176/appi.ajp.2015.14050680. Epub 2015 Mar 27.

PMID:
25815420
10.

Tryptophan hydroxylase 2 gene is associated with major depression and antidepressant treatment response.

Tsai SJ, Hong CJ, Liou YJ, Yu YW, Chen TJ, Hou SJ, Yen FC.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Jun 15;33(4):637-41. doi: 10.1016/j.pnpbp.2009.02.020. Epub 2009 Mar 9.

PMID:
19272410
11.

Antidepressants and ABCB1 gene C3435T functional polymorphism: a naturalistic study.

Menu P, Gressier F, Verstuyft C, Hardy P, Becquemont L, Corruble E.

Neuropsychobiology. 2010 Aug;62(3):193-7. doi: 10.1159/000319361. Epub 2010 Jul 22.

PMID:
20664232
12.

Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment.

Papiol S, Arias B, Gastó C, Gutiérrez B, Catalán R, Fañanás L.

J Affect Disord. 2007 Dec;104(1-3):83-90. Epub 2007 Apr 30.

PMID:
17467808
13.

SLC6A4 polymorphisms and age of onset in late-life depression on treatment outcomes with citalopram: a Sequenced Treatment Alternatives to Relieve Depression (STAR*D) report.

Shiroma PR, Drews MS, Geske JR, Mrazek DA.

Am J Geriatr Psychiatry. 2014 Nov;22(11):1140-8. doi: 10.1016/j.jagp.2013.02.012. Epub 2013 Aug 20.

14.

Analysis of COMT gene (Val 158 Met polymorphism) in the clinical response to SSRIs in depressive patients of European origin.

Arias B, Serretti A, Lorenzi C, Gastó C, Catalán R, Fañanás L.

J Affect Disord. 2006 Feb;90(2-3):251-6. Epub 2005 Dec 13.

PMID:
16356553
15.

Association of ABCB1 polymorphisms and ulcerative colitis susceptibility.

Cao Y, Qu C, Chen Y, Li L, Wang X.

Int J Clin Exp Pathol. 2015 Jan 1;8(1):943-7. eCollection 2015.

16.

Serotonin transporter polymorphism (5-HTTLPR) and citalopram effectiveness and side effects in children with depression and/or anxiety disorders.

Kronenberg S, Apter A, Brent D, Schirman S, Melhem N, Pick N, Gothelf D, Carmel M, Frisch A, Weizman A.

J Child Adolesc Psychopharmacol. 2007 Dec;17(6):741-50. doi: 10.1089/cap.2006.0144.

PMID:
18315446
17.

Acute antidepressive efficacy of lithium monotherapy, not citalopram, depends on recurrent course of depression.

Bschor T, Uhr M, Baethge C, Lewitzka U, Ising M, Erbe S, Winkelmann P, Ritter D.

J Clin Psychopharmacol. 2013 Feb;33(1):38-44. doi: 10.1097/JCP.0b013e31827b9495.

PMID:
23277245
18.

Association of polymorphisms in genes regulating the corticotropin-releasing factor system with antidepressant treatment response.

Binder EB, Owens MJ, Liu W, Deveau TC, Rush AJ, Trivedi MH, Fava M, Bradley B, Ressler KJ, Nemeroff CB.

Arch Gen Psychiatry. 2010 Apr;67(4):369-79. doi: 10.1001/archgenpsychiatry.2010.18.

PMID:
20368512
19.

The FKBP5-gene in depression and treatment response--an association study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Cohort.

Lekman M, Laje G, Charney D, Rush AJ, Wilson AF, Sorant AJ, Lipsky R, Wisniewski SR, Manji H, McMahon FJ, Paddock S.

Biol Psychiatry. 2008 Jun 15;63(12):1103-10. doi: 10.1016/j.biopsych.2007.10.026. Epub 2008 Jan 11.

20.
Items per page

Supplemental Content

Write to the Help Desk